These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 19653237)

  • 1. Comparison of adverse events between oral and intravenous formulations of antimicrobial agents: a systematic review of the evidence from randomized trials.
    Kouranos VD; Karageorgopoulos DE; Peppas G; Falagas ME
    Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):873-9. PubMed ID: 19653237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and tolerability of intravenous-to-oral treatment and single-dose intravenous or oral prophylaxis with trovafloxacin.
    Williams DJ; Hopkins S
    Am J Surg; 1998 Dec; 176(6A Suppl):74S-79S. PubMed ID: 9935261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonates for breast cancer.
    Pavlakis N; Stockler M
    Cochrane Database Syst Rev; 2002; (1):CD003474. PubMed ID: 11869664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early switch to oral versus intravenous antimicrobial treatment for hospitalized patients with acute pyelonephritis: a systematic review of randomized controlled trials.
    Vouloumanou EK; Rafailidis PI; Kazantzi MS; Athanasiou S; Falagas ME
    Curr Med Res Opin; 2008 Dec; 24(12):3423-34. PubMed ID: 19032124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse events of fluoroquinolones vs. other antimicrobials prescribed in primary care: A systematic review and meta-analysis of randomized controlled trials.
    Tandan M; Cormican M; Vellinga A
    Int J Antimicrob Agents; 2018 Nov; 52(5):529-540. PubMed ID: 29702230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective analysis of the safety profile of oral and intravenous ciprofloxacin in a geriatric population.
    Heyd A; Haverstock D
    Clin Ther; 2000 Oct; 22(10):1239-50. PubMed ID: 11110234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of complicated intra-abdominal infections: comparison of the tolerability and safety of intravenous/oral trovafloxacin versus intravenous imipenem/cilastatin switching to oral amoxycillin/clavulanic acid.
    Luke DR; Peterson J
    Int J Clin Pract; 1999; 53(3):166-73. PubMed ID: 10665126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and tolerability of linezolid in children.
    Saiman L; Goldfarb J; Kaplan SA; Wible K; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
    Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S193-200. PubMed ID: 14520146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and tolerance of single- and multiple-dose oral or intravenous linezolid, an oxazolidinone antibiotic, in healthy volunteers.
    Stalker DJ; Jungbluth GL; Hopkins NK; Batts DH
    J Antimicrob Chemother; 2003 May; 51(5):1239-46. PubMed ID: 12668582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy of oral linezolid compared with intravenous vancomycin for the treatment of methicillin-resistant Staphylococcus aureus-complicated skin and soft tissue infections: a retrospective, propensity score-matched, case-control analysis.
    Itani KM; Biswas P; Reisman A; Bhattacharyya H; Baruch AM
    Clin Ther; 2012 Aug; 34(8):1667-73.e1. PubMed ID: 22770644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moxifloxacin and glucose homeostasis: a pooled-analysis of the evidence from clinical and postmarketing studies.
    Gavin JR; Kubin R; Choudhri S; Kubitza D; Himmel H; Gross R; Meyer JM
    Drug Saf; 2004; 27(9):671-86. PubMed ID: 15230648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral antibiotics for fever in low-risk neutropenic patients with cancer: a double-blind, randomized, multicenter trial comparing single daily moxifloxacin with twice daily ciprofloxacin plus amoxicillin/clavulanic acid combination therapy--EORTC infectious diseases group trial XV.
    Kern WV; Marchetti O; Drgona L; Akan H; Aoun M; Akova M; de Bock R; Paesmans M; Viscoli C; Calandra T
    J Clin Oncol; 2013 Mar; 31(9):1149-56. PubMed ID: 23358983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transition from intravenous to oral antimicrobial therapy in patients with uncomplicated and complicated bloodstream infections.
    Al-Hasan MN; Rac H
    Clin Microbiol Infect; 2020 Mar; 26(3):299-306. PubMed ID: 31128289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of oral antimicrobial therapy in the management of osteomyelitis.
    Shuford JA; Steckelberg JM
    Curr Opin Infect Dis; 2003 Dec; 16(6):515-9. PubMed ID: 14624099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotoxicity with antimicrobials in the elderly: a review.
    Mattappalil A; Mergenhagen KA
    Clin Ther; 2014 Nov; 36(11):1489-1511.e4. PubMed ID: 25450476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and tolerability of the antimicrobial peptide human lactoferrin 1-11 (hLF1-11).
    Velden WJ; van Iersel TM; Blijlevens NM; Donnelly JP
    BMC Med; 2009 Sep; 7():44. PubMed ID: 19735580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged antimicrobial and oral cyclophosphamide therapy in pemphigus: need for caution.
    Ramam M
    Indian J Dermatol Venereol Leprol; 2009; 75(1):85. PubMed ID: 19172046
    [No Abstract]   [Full Text] [Related]  

  • 18. "Big Clinical Data" Analysis of Intravenous to Oral Conversions of Non-Antimicrobials.
    Beeler PE; Bates DW; Blaser J
    Stud Health Technol Inform; 2017; 245():1251. PubMed ID: 29295336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addressing Concerns about Changing the Route of Antimicrobial Administration from Intravenous to Oral in Adult Inpatients.
    Béïque L; Zvonar R
    Can J Hosp Pharm; 2015; 68(4):318-26. PubMed ID: 26327706
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.